Pfizer Inc. said Tuesday it will defer some recent drug-price increases, reversing course after President Donald Trump criticized the company.

The New York-based drug maker, one of the world’s biggest pharmaceutical companies by sales, had faced criticism from Mr. Trump and others after raising the prices of more than 40 drugs last week.

Pfizer...